welcome to
Medoja Bio Private Limited
Medoja Bio Private Limited is dedicated to developing environment-friendly biomaterials and nanobiomaterials, offering customizable solutions at both laboratory and industrial scales. Our mission is to provide advanced materials precisely tailored to the unique requirements of our clients, ensuring each product meets their specific scientific and operational needs.
The foundation of Medoja Bio was laid during the final year of our Director’s PhD, where the research group focused on creating ceramic 3D-printed bone grafts for bone tissue engineering. Recognizing the potential impact of his innovation, the idea was selected for BIRAC’s BIG Call 14 initiative, enabling the team to transform academic research into a viable commercial product. Despite the challenges posed by the COVID-19 pandemic from early 2020 to October 2022, our researchers refined the technology through in-depth in vitro and in vivo studies, culminating in extensive pre-clinical evaluations of the bone graft formulation.
This research led to a synthetic calcium phosphate-based bone graft featuring inherent angio-induction and osteo-induction properties, marking a significant advancement in bone regeneration. The technology underwent pilot clinical studies in around 20 patients, particularly in periodontal applications, with promising outcomes. Building on this success, Medoja Bio Pvt. Ltd. was officially incorporated in November 2022. The name “Medoja,” derived from Sanskrit and symbolizing “bone,” reflects our core mission, driving scientific innovation to enhance bone regeneration technologies.
Medoja Bio Private Limited is dedicated to the production of environment friendly biomaterials and nanobiomaterials, utilizing readily available natural resources, primarily derived from fish, shrimp, egg processing industries, as well as vegetable, fruit processing, and dairy industries. By transforming this waste into valuable materials, we aim to promote environmental sustainability.